Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jonas

Showing results (531-540 of 557) with videos related to

Pageof 56
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 23, 2013
Comparison of fondaparinux with low molecular weight heparin for venous thromboembolism prevention in patients requiring rigid or semi-rigid immobilization for isolated non-surgical below-knee injuryC M Samama, N Lecoules, G Kierzek, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 27, 2009
Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomesJames R Rodrigue, William Balistreri, Barbara Haber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2026
Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation StudyFabian Kahl, Ann-Kathrin Schalkamp, Katarina Mary Gunter, et al.
Hepatology (Baltimore, Md.)|December 21, 2016
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infectionWilliam F Balistreri, Karen F Murray, Philip Rosenthal, et al.
Hepatology (Baltimore, Md.)|March 3, 2012
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trialMaureen M Jonas, William Balistreri, Regino P Gonzalez-Peralta, et al.
Hepatology (Baltimore, Md.)|January 2, 2008
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C TrialZachary D Goodman, Hala R Makhlouf, Lea Liu, et al.
Hepatology (Baltimore, Md.)|February 26, 2011
Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in childrenJames R Rodrigue, William Balistreri, Barbara Haber, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infectionStefan Wirth, Philip Rosenthal, Regino P Gonzalez-Peralta, et al.
Journal of Viral Hepatitis|March 13, 2012
Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirinD A Kelly, B Haber, R P González-Peralta, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 27, 2013
Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis CJean P Molleston, William Mellman, Michael R Narkewicz, et al.
Pageof 56

Showing results (531-540 of 557) with videos related to

Sort By:
Pageof 56
Journal of Thrombosis and Haemostasis : JTH|August 23, 2013
Comparison of fondaparinux with low molecular weight heparin for venous thromboembolism prevention in patients requiring rigid or semi-rigid immobilization for isolated non-surgical below-knee injuryC M Samama, N Lecoules, G Kierzek, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 27, 2009
Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomesJames R Rodrigue, William Balistreri, Barbara Haber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2026
Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation StudyFabian Kahl, Ann-Kathrin Schalkamp, Katarina Mary Gunter, et al.
Hepatology (Baltimore, Md.)|December 21, 2016
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infectionWilliam F Balistreri, Karen F Murray, Philip Rosenthal, et al.
Hepatology (Baltimore, Md.)|March 3, 2012
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trialMaureen M Jonas, William Balistreri, Regino P Gonzalez-Peralta, et al.
Hepatology (Baltimore, Md.)|January 2, 2008
Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C TrialZachary D Goodman, Hala R Makhlouf, Lea Liu, et al.
Hepatology (Baltimore, Md.)|February 26, 2011
Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in childrenJames R Rodrigue, William Balistreri, Barbara Haber, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infectionStefan Wirth, Philip Rosenthal, Regino P Gonzalez-Peralta, et al.
Journal of Viral Hepatitis|March 13, 2012
Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirinD A Kelly, B Haber, R P González-Peralta, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 27, 2013
Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis CJean P Molleston, William Mellman, Michael R Narkewicz, et al.
Pageof 56